Biologics

The global orthobiologics market is predicted to reach $6.06 billion by 2022, growing at a compounded annual rate of 5.4 percent.

DiscGenics closed a Series B financing round.

Columbia-based University of Missouri School of Medicine researchers studied bone marrow aspirate concentrate's impact on knee joint transplant outcomes.

Vail-Summit Orthopaedics will offer platelet-rich plasma and stem cell injections at its Colorado-based locations in Edwards, Frisco and Vail.

Atlanta-based Orthopedic and Back Pain Centers of America added The Dallas PRP and Stem Cell Institute to its network.

The FDA issued a warning letter to the Sunrise, Fla.-based US Stem Cell Clinic for inaccurate marketing of its stem cell products as well as other deviations, according to the FDA.

Regenerative Biologics Institute opened the doors of its new facility in Vero Beach, Fla.

Here are 16 points on spinal fusions.

Boise, Idaho-based Burst Biologics will begin a study involving spinal fusion patients.

Huntley, Ill.-based Life Spine reported record revenue growth of 424 percent in the past fiscal year for its biologics product line.